| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15,620 |
11,741 |
$426K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
6,673 |
2,835 |
$223K |
| 99205 |
Prolong outpt/office vis |
2,513 |
1,930 |
$154K |
| 99215 |
Prolong outpt/office vis |
3,285 |
2,413 |
$129K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,111 |
4,795 |
$121K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,233 |
931 |
$61K |
| J9271 |
Injection, pembrolizumab, 1 mg |
44 |
25 |
$50K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,119 |
863 |
$46K |
| 96417 |
|
1,735 |
878 |
$41K |
| 99195 |
|
1,044 |
614 |
$25K |
| 96401 |
|
728 |
479 |
$15K |
| 96416 |
|
472 |
115 |
$14K |
| 96411 |
|
662 |
286 |
$14K |
| 96367 |
|
3,928 |
1,973 |
$10K |
| 96415 |
|
960 |
408 |
$9K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,014 |
1,671 |
$8K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
1,472 |
557 |
$7K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,110 |
1,613 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,051 |
1,125 |
$5K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
4,126 |
1,628 |
$5K |
| 96402 |
|
425 |
310 |
$4K |
| J1453 |
Injection, fosaprepitant, 1 mg |
111 |
57 |
$2K |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
516 |
253 |
$2K |
| J9190 |
Injection, fluorouracil, 500 mg |
642 |
83 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,419 |
1,725 |
$872.45 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,071 |
915 |
$851.33 |
| 36591 |
|
459 |
219 |
$846.29 |
| 99223 |
Prolong inpt eval add15 m |
17 |
14 |
$824.33 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
46 |
40 |
$668.38 |
| J3490 |
Unclassified drugs |
1,323 |
693 |
$663.33 |
| J3489 |
Injection, zoledronic acid, 1 mg |
16 |
13 |
$199.45 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
109 |
53 |
$186.82 |
| 96377 |
|
72 |
37 |
$177.64 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
332 |
245 |
$160.86 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
227 |
92 |
$90.61 |
| 96368 |
|
260 |
130 |
$48.70 |
| J2780 |
Injection, ranitidine hydrochloride, 25 mg |
27 |
15 |
$47.91 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
75 |
40 |
$7.22 |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
366 |
234 |
$0.92 |
| S0028 |
Injection, famotidine, 20 mg |
57 |
45 |
$0.00 |
| 96523 |
|
38 |
14 |
$0.00 |